Please select the option that best describes you:

Would you add whole-pelvis radiation as MDT (metastasis-directed therapy) in a patient with 1 pelvic node and 2 osseous metastatic sites for castrate-resistant prostate cancer?  

Patient had RP as initial treatment, GS 4+4, pT3 (ECE) pN0 (0 of 18), adjuvant 70.2 Gy to prostatic fossa, then developed BCR and eventually PSMA PET CT demonstrated oligometastatic (3 sites) disease while on ADT. Abiraterone was added. My plan was to offer SBRT to the 3 PET-positive sites, but the patient and family want to be aggressive, requesting the whole pelvis be treated as well. Does the recent PEACE V- STORM trial impact your decision?



Answer from: Radiation Oncologist at Academic Institution
Sign in or Register to read more

Answer from: Radiation Oncologist at Academic Institution
Sign in or Register to read more

Answer from: Radiation Oncologist at Community Practice
Comments
Radiation Oncologist at UC San Diego
Great catch! I agree it doesn’t change the a...
Radiation Oncologist at Hôtel Dieu de Lévis - CISSS Chaudière-Appalaches
Thank you! It is buried in the supplementary mater...
Sign in or Register to read more